Successful treatment of refractory extensive pityriasis rubra pilaris with risankizumab
- PMID: 33274752
- DOI: 10.1111/bjd.19681
Successful treatment of refractory extensive pityriasis rubra pilaris with risankizumab
Comment in
-
Response to: 'Successful treatment of refractory extensive pityriasis rubra pilaris with risankizumab'.Br J Dermatol. 2021 Jul;185(1):235-236. doi: 10.1111/bjd.20061. Epub 2021 Apr 18. Br J Dermatol. 2021. PMID: 33730424 No abstract available.
References
-
- Feldmeyer L, Mylonas A, Demaria O et al. Interleukin 23-helper T cell 17 axis as a treatment target for pityriasis rubra pilaris. JAMA Dermatol 2017; 153:304-8.
-
- Pilz AC, Seiringer P, Biedermann T, Eyerich K. Treatment of pityriasis rubra pilaris with guselkumab. JAMA Dermatol 2019; 155:1424-6.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
